Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Seres Therapeutics Inc’s stock clocked out at $1.27, up 6.72% from its previous closing price of $1.19. In other words, the price has increased by $6.72 from its previous closing price. On the day, 11.21 million shares were traded. MCRB stock price reached its highest trading level at $1.44 during the session, while it also had its lowest trading level at $1.19.
Ratios:
To gain a deeper understanding of MCRB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.25 and its Current Ratio is at 1.68.
On April 21, 2023, JP Morgan started tracking the stock assigning a Neutral rating and target price of $7.
Goldman Downgraded its Neutral to Sell on July 23, 2021, whereas the target price for the stock was revised from $24 to $7.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 15 ’24 when Shaff Eric D. sold 2,435 shares for $0.94 per share. The transaction valued at 2,289 led to the insider holds 140,698 shares of the business.
Ege David S. sold 1,090 shares of MCRB for $1,025 on May 15 ’24. The insider now owns 75,734 shares after completing the transaction at $0.94 per share. On May 15 ’24, another insider, von Moltke Lisa, who serves as the insider of the company, sold 939 shares for $0.94 each. As a result, the insider received 883 and left with 19,017 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MCRB now has a Market Capitalization of 192338960 and an Enterprise Value of 295337664. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.52. Its current Enterprise Value per Revenue stands at 2.328 whereas that against EBITDA is -4.183.
Stock Price History:
The Beta on a monthly basis for MCRB is 2.02, which has changed by -0.73093224 over the last 52 weeks, in comparison to a change of 0.24125004 over the same period for the S&P500. Over the past 52 weeks, MCRB has reached a high of $5.29, while it has fallen to a 52-week low of $0.54. The 50-Day Moving Average of the stock is 41.84%, while the 200-Day Moving Average is calculated to be 16.89%.
Shares Statistics:
It appears that MCRB traded 4.81M shares on average per day over the past three months and 4743780 shares per day over the past ten days. A total of 135.04M shares are outstanding, with a floating share count of 119.86M. Insiders hold about 20.86% of the company’s shares, while institutions hold 41.43% stake in the company. Shares short for MCRB as of 1719532800 were 20686202 with a Short Ratio of 4.30, compared to 1717113600 on 22596209. Therefore, it implies a Short% of Shares Outstanding of 20686202 and a Short% of Float of 19.11.
